Protein N-glycosylation in oral cancer: Dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signaling

Glycobiology

Volumn 24, Issue 7, 2014, Pages 579-591

  Varelas, Xaralabos ^a   Bouchie, Meghan P ^b   Kukuruzinska, Maria A ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

cancer; DPAGT1; E cadherin; N glycosylation; Wnt signaling

Indexed keywords

BETA CATENIN; DOLICHOL PHOSPHATE; GLUCOSE; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINE 1 PHOSPHOTRANSFERASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOTRANSFERASE; PLAKOGLOBIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN; CADHERIN; DOLICHYL-PHOSPHATE ALPHA-N-ACETYLGLUCOSAMINYLTRANSFERASE; N ACETYLGLUCOSAMINYLTRANSFERASE;

ACTIN FILAMENT; BINDING SITE; CARCINOGENESIS; CELL ADHESION; CELL CONTACT; CELL JUNCTION; CELL MATURATION; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM; FEEDBACK SYSTEM; GENE EXPRESSION REGULATION; MOLECULAR SIZE; MOUTH CANCER; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN N GLYCOSYLATION; PROTEIN STRUCTURE; REVIEW; TIGHT JUNCTION; TRANSCRIPTION REGULATION; UPREGULATION; WNT SIGNALING PATHWAY; ANIMAL; ENZYMOLOGY; GLYCOSYLATION; HUMAN; METABOLISM; MOUTH TUMOR; PROTEIN PROCESSING;

ANIMALS; CADHERINS; CELL ADHESION; FEEDBACK, PHYSIOLOGICAL; GLYCOSYLATION; HUMANS; MOUTH NEOPLASMS; N-ACETYLGLUCOSAMINYLTRANSFERASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; WNT SIGNALING PATHWAY;

EID: 84901791985     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwu031     Document Type: Review

References (163)

1. Aebi M. 2013. N-linked protein glycosylation in the ER. Biochim Biophys Acta. 1833:2430-2437.
2. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, et al. 2011. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 333:1154-1157.
3. Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, Espada J, Garcia JM, Munoz A, Esteller M, Gonzalez-Sancho JM. 2006. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene. 25:4116-4121. (Pubitemid 44024874)
4. Anagnostou SH, Shepherd PR. 2008. Glucose induces an autocrine activation of the Wnt/beta-catenin pathway in macrophage cell lines. Biochem J. 416:211-218.
5. Ando-Akatsuka Y, Yonemura S, Itoh M, Furuse M, Tsukita S. 1999. Differential behavior of E-cadherin and occludin in their colocalization with ZO-1 during the establishment of epithelial cell polarity. J Cell Physiol. 179:115-125. (Pubitemid 29165139)
6. Beavon IR. 2000. The E-cadherin-catenin complex in tumour metastasis: Structure, function and regulation. Eur J Cancer. 36:1607-1620. (Pubitemid 30616365)
7. Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A. 2003. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: A comparison with Snail and E47 repressors. J Cell Sci. 116:499-511. (Pubitemid 36231290)
8. Brembeck FH, Rosario M, Birchmeier W. 2006. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev. 16:51-59. (Pubitemid 43089612)
9. Bretthauer RK. 2009. Structure, expression, and regulation of UDP-GlcNAc: Dolichol phosphate GlcNAc-1-phosphate transferase (DPAGT1). Curr Drug Targets. 10:477-482.
10. Carrera IA, Matthijs G, Perez B, Cerda CP. 2012. DPAGT1-CDG: Report of a patient with fetal hypokinesia phenotype. Am J Med Genet A. 158A:2027-2030.
11. Cassell A, Grandis JR. 2010. Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma. Expert Opin Investig Drugs. 19:709-722.
12. Choi S, Myers JN. 2008. Molecular pathogenesis of oral squamous cell carcinoma: Implications for therapy. J Dent Res. 87:14-32.
13. Clark GF, Miller KR, Smith PB. 1983. Formation of dolichol-linked sugar intermediates during the postnatal development of skeletal muscle. J Biol Chem. 258:14263-14270. (Pubitemid 14217946)
14. Clevers H, Nusse R. 2012. Wnt/beta-catenin signaling and disease. Cell. 149:1192-1205.
15. Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A. 2003. Autoregulation of E-cadherin expression by cadherincadherin interactions: The roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol. 163:847-857. (Pubitemid 37517891)
16. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. 2002. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest. 109:987-991. (Pubitemid 34408571)
17. Contessa JN, Bhojani MS, Freeze HH, Rehemtulla A, Lawrence TS. 2008. Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells. Cancer Res. 68:3803-3809.
18. Datta AK, Lehrman MA. 1993. Both potential dolichol recognition sequences of hamster GlcNAc-1-phosphate transferase are necessary for normal enzyme function. J Biol Chem. 268:12663-12668. (Pubitemid 23182430)
19. de-Freitas-Junior JC, Bastos LG, Freire-Neto CA, Rocher BD, Abdelhay ES, Morgado-Diaz JA. 2012. N-Glycan biosynthesis inhibitors induce in vitro anticancer activity in colorectal cancer cells. J Cell Biochem. 113:2957-2966.
20. Dennis JW, Laferte S, Waghorne C, Breitman MC, Kerbel R. 1987. Beta 1,6-branching of Asn-linked oligosaccaride is directly associated with metastases. Science. 236:582-585. (Pubitemid 17069927)
21. Dennis JW, Nabi IR, Demetriou M. 2009. Metabolism, cell surface organization, and disease. Cell. 139:1229-1241.
22. Desai RA, Gao L, Raghavan S, Liu WF, Chen CS. 2009. Cell polarity triggered by cell-cell adhesion via E-cadherin. J Cell Sci. 122:905-911.
23. Dhillon AS, Hagan S, Rath O, KolchW. 2007. MAP kinase signalling pathways in cancer. Oncogene. 26:3279-3290. (Pubitemid 46763021)
24. Doki Y, Shiozaki H, Tahara H, Inoue M, Oka H, Iihara K, Kadowaki T, Takeichi M, Mori T. 1993. Correlation between E-cadherin expression and invasiveness in vitro in a human esophageal cancer cell line. Cancer Res. 15:3421-3426. (Pubitemid 23223320)
25. Drees F, Pokutta S, Yamada S, Nelson WJ, Weis WI. 2005. Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin filament assembly. Cell. 123:903-915. (Pubitemid 41721035)
26. Fernandes RP, Cotanche DA, Lennon-Hopkins K, Erkan F, Menko AS, Kukuruzinska MA. 1999. Differential expression of proliferative, cytoskeletal, and adhesive proteins during postnatal development of the hamster submandibular gland. Histochem Cell Biol. 111:153-162. (Pubitemid 29148255)
27. Fodde R, Brabletz T. 2007. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol. 19:150-158. (Pubitemid 46386404)
28. Gofuku J, Shiozaki H, Tsujinaka T, Inoue M, Tamura S, Doki Y, Matsui S, Tsukita S, Kikkawa N, Monden M. 1999. Expression of E-cadherin and alpha-catenin in patients with colorectal carcinoma. Correlation with cancer invasion and metastasis. Am J Clin Pathol. 111:29-37. (Pubitemid 29024963)
29. Gottardi CJ, Wong E, Gumbiner BM. 2001. E-cadherin suppresses cellular transformation by inhibiting b-catenin signaling in an adhesion-independent manner. J Cell Biol. 153:1049-1059. (Pubitemid 34289243)
30. Gumbiner BM. 2005. Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol. 6:622-634. (Pubitemid 41081266)
31. Guo HB, Johnson H, Randolph M, Nagy T, Blalock R, Pierce M. 2010. Specific posttranslational modification regulates early events in mammary carcinoma formation. Proc Natl Acad Sci USA. 107:21116-21121.
32. Guo HB, Johnson H, Randolph M, Pierce M. 2009. Regulation of homotypic cell-cell adhesion by branched N-glycosylation of N-cadherin extracellular EC2 and EC3 domains. J Biol Chem. 284:34986-34997.
33. Guo HB, Lee I, Kamar M, Pierce M. 2003. N-acetylglucosaminyltransferase V expression levels regulate cadherin-associated homotypic cell-cell adhesion and intracellular signaling pathways. J Biol Chem. 278:52412-52424. (Pubitemid 38035833)
34. Guo H, Nairn A, dela Rosa M, Nagy T, Zhao S, Moremen K, Pierce M. 2012. Transcriptional regulation of the protocadherin beta cluster during Her-2 protein-induced mammary tumorigenesis results from altered N-glycan branching. J Biol Chem. 287:24941-24954.
35. Guturi KK, Mandal T, Chatterjee A, Sarkar M, Bhattacharya S, Chatterjee U, Ghosh MK. 2012. Mechanism of beta-catenin-mediated transcriptional regulation of epidermal growth factor receptor expression in glycogen synthase kinase 3 beta-inactivated prostate cancer cells. J Biol Chem. 287: 18287-18296.
36. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: The next generation. Cell. 144:646-674.
37. Harada H, Itasaka S, Kizaka-Kondoh S, Shibuya K, Morinibu A, Shinomiya K, Hiraoka M. 2009. The Akt/mTOR pathway assures the synthesis of HIF-1alpha protein in a glucose-and reoxygenation-dependent manner in irradiated tumors. J Biol Chem. 284:5332-5342.
38. Hartsock A, Nelson WJ. 2008. Adherens and tight junctions: Structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta. 1778:660-669. (Pubitemid 351317795)
39. Haugsten EM, Wiedlocha A, Olsnes S, Wesche J. 2010. Roles of fibroblast growth factor receptors in carcinogenesis. Mol Cancer Res. 8:1439-1452.
40. Hayes GR, Lucas JJ. 1983. Stimulation of lipid-linked oligosaccharide assembly during oviduct differentiation. J Biol Chem. 258:15095-15100. (Pubitemid 14178942)
41. Heifetz A, Keenan RW, Elbein AD. 1979. Mechanism of action of tunicamycin on the UDP-GlcNAc:dolichyl-phosphate Glc-NAc-1-phosphate transferase. Biochemistry. 18:2186-2192.
42. Helenius A, Aebi M. 2001. Intracellular functions of N-linked glycans. Science. 291:2364-2369. (Pubitemid 32231791)
43. Heuberger J, Birchmeier W. 2010. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol. 2:a002915.
44. Hiss DC, Gabriels GA, Folb PI. 2007. Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells. Cancer Cell Int. 7:5.
45. Hong S, Troyanovsky RB, Troyanovsky SM. 2013. Binding to F-actin guides cadherin cluster assembly, stability, and movement. J Cell Biol. 201:131-143.
46. Hou H, Sun H, Lu P, Ge C, Zhang L, Li H, Zhao F, Tian H, Zhang L, Chen T, et al. 2013. Tunicamycin potentiates cisplatin anticancer efficacy through the DPAGT1/Akt/ABCG2 pathway in mouse Xenograft models of human hepatocellular carcinoma. Mol Cancer Ther. 12:2874-2884.
47. Huang GT, Lennon K, Kukuruzinska MA. 1998. Characterization of multiple transcripts of the hamster dolichol-P-dependent N-acetylglucosamine-1-P transferase suggests functionally complex expression. Mol Cell Biochem. 181:97-106. (Pubitemid 28127782)
48. Huveneers S, de Rooij J. 2013. Mechanosensitive systems at the cadherin-F-actin interface. J Cell Sci. 126:403-413.
49. Imamura Y, Itoh M, Maeno Y, Tsukita S, Nagafuchi A. 1999. Functional domains of alpha-catenin required for the strong state of cadherin-based cell adhesion. J Cell Biol. 144:1311-1322. (Pubitemid 29157307)
50. Jain S, Suzuki T, Seth A, Samak G, Rao R. 2011. Protein kinase Czeta phosphorylates occludin and promotes assembly of epithelial tight junctions. Biochem J. 437:289-299.
51. Jamal BT, Nita-Lazar M, Gao Z, Amin B, Walker J, Kukuruzinska MA. 2009. N-Glycosylation status of E-cadherin controls cytoskeletal dynamics through the organization of distinct beta-catenin-and gamma-catenin-containing AJs. Cell Health Cytoskelet. 2009:67-80.
52. Jamal B, Sengupta PK, Gao ZN, Nita-Lazar M, Amin B, Jalisi S, Bouchie MP, Kukuruzinska MA. 2012. Aberrant amplification of the crosstalk between canonical Wnt signaling and N-glycosylation gene DPAGT1 promotes oral cancer. Oral Oncol. 48:523-529.
53. Jamora C, Fuchs E. 2002. Intercellular adhesion, signalling and the cytoskeleton. Nat Cell Biol. 4:101-108.
54. Jung H, Lee SK, Jho EH. 2011. Mest/Peg1 inhibits Wnt signalling through regulation of LRP6 glycosylation. Biochem J. 436:263-269.
55. Kam Y, Quaranta V. 2009. Cadherin-bound beta-catenin feeds into the Wnt pathway upon adherens junctions dissociation: Evidence for an intersection between beta-catenin pools. PLoS ONE. 4:e4580.
56. Khan Z, Vijayakumar S, de la Torre TV, Rotolo S, Bafico A. 2007. Analysis of endogenous LRP6 function reveals a novel feedback mechanism by which Wnt negatively regulates its receptor. Mol Cell Biol. 27:7291-7301. (Pubitemid 47549762)
57. Kim YW, Park J, Lee HJ, Lee SY, Kim SJ. 2012. TGFβ sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor. Biochem J. 445:403-411.
58. Kitada T, Miyoshi E, Noda K, Higashiyama S, Ihara H, Matsuura N, Hayashi N, Kawata S, Matsuzawa Y, Taniguchi N. 2001. The addition of bisecting N-acetylglucosamine residues to E-cadherin down-regulates the tyrosine phosphorylation of b-catenin. J Biol Chem. 276:475-480. (Pubitemid 32050341)
59. Klebl B, Kozian D, Leberer E, Kukuruzinska MA. 2001. A comprehensive analysis of gene expression profiles in a yeast N-glycosylation mutant. Biochem Biophys Res Commun. 286:714-720. (Pubitemid 32912946)
60. Komekado H, Yamamoto H, Chiba T, Kikuchi A. 2007. Glycosylation and palmitoylation of Wnt-3a are coupled to produce an active form of Wnt-3a. Genes Cells. 12:521-534. (Pubitemid 46488587)
61. Konishi A, Berk BC. 2003. Epidermal growth factor receptor transactivation is regulated by glucose in vascular smooth muscle cells. J Biol Chem. 278:35049-35056. (Pubitemid 37102266)
62. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ, Clevers H. 1998. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet. 19:379-383. (Pubitemid 28357912)
63. Kukuruzinska MA, Lennon K. 1994. Growth-related coordinate regulation of the early N-glycosylation genes in yeast. Glycobiol. 4:437-443. (Pubitemid 24277766)
64. Kukuruzinska MA, Lennon K. 1995. Diminished activity of the first N-glycosylation enzyme, dolichol-P-dependent N-acetylglucosamine-1-P transferase (GPT), gives rise to mutant phenotypes. Biochem Biophys Acta. 1247:51-59.
65. Kukuruzinska MA, Lennon-Hopkins K. 1999. ALG gene expression and cell cycle progression. Biochem Biophys Acta. 1426:359-372. (Pubitemid 29027951)
66. Kukuruzinska MA, Robbins PW. 1987. Protein glycosylation in yeast: Transcript heterogeneity of the ALG7 gene. Proc Natl Acad Sci USA. 84:2145-2149. (Pubitemid 17075827)
67. Kuroda S, Fukata M, Nakagawa M, Fujii K, Nakamura T, Ookubo T, Izawa I, Nagase T, Nomura N, Tani H, et al. 1998. Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin-mediated cellcell adhesion. Science. 281:832-835. (Pubitemid 28376045)
68. Lajoie P, Partridge EA, Guay G, Goetz JG, Pawling J, Lagana A, Joshi B, Dennis JW, Nabi IR. 2007. Plasma membrane domain organization regulates EGFR signaling in tumor cells. J Cell Biol. 179:341-356. (Pubitemid 350004897)
69. Langer MD, Guo H, Shashikanth N, Pierce JM, Leckband DE. 2012. N-Glycosylation alters cadherin-mediated intercellular binding kinetics. J Cell Sci. 125:2478-2485.
70. Lau KS, Dennis JW. 2008. N-Glycans in cancer progression. Glycobiology. 18:750-760.
71. Lau KS, Partridge EA, Grigorian A, Silvescu CI, Reinhold VN, Demetriou M, Dennis JW. 2007. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell. 129:123-134. (Pubitemid 46507588)
72. le Duc Q, Shi Q, Blonk I, Sonnenberg A, Wang N, Leckband D, de Rooij J. 2010. Vinculin potentiates E-cadherin mechanosensing and is recruited to actin-anchored sites within adherens junctions in a myosin II-dependent manner. J Cell Biol. 189:1107-1115.
73. Le Good JA, Joubin K, Giraldez AJ, Ben-Haim N, Beck S, Chen Y, Schier AF, Constam DB. 2005. Nodal stability determines signaling range. Curr Biol. 15:31-36. (Pubitemid 40099247)
74. Lee CH, Hung HW, Hung PH, Shieh YS. 2010. Epidermal growth factor receptor regulates beta-catenin location, stability, and transcriptional activity in oral cancer. Mol Cancer. 9:64.
75. Leemans CR, Braakhuis BJ, Brakenhoff RH. 2011. The molecular biology of head and neck cancer. Nat Rev Cancer. 11:9-22.
76. Lehle L, Tanner W. 1976. The specific site of tunicamycin inhibition in the formation of dolichol-bound N-acetylglucosamine derivatives. FEBS Lett. 71:167-170.
77. Lehrman MA, Zhu XY, Khounlo S. 1988. Amplification and molecular cloning of the hamster tunicamycin-sensitive N-acetylglucosamine-1-phosphate transferase gene. The hamster and yeast enzymes share a common peptide sequence. J Biol Chem. 263:19796-19803. (Pubitemid 19016464)
78. Lennon K, Bird A, Chen Y-F, Pretel R, Kukuruzinska MA. 1997. The dual role of mRNA half-lives in the expression of the yeast ALG7 gene. Mol Cell Biochem. 169:95-106. (Pubitemid 27116964)
79. Lennon K, Pretel R, Kesselheim J, te Heesen S, Kukuruzinska MA. 1995. Proliferation-dependent differential regulation of the dolichol pathway genes in Saccharomyces cerevisiae. Glycobiology. 5:633-642.
80. Ligon LA, Karki S, Tokito M, Holzbaur ELF. 2001. Dynein binds to betacatenin and may tether microtubules at adherens junctions. Nature Cell Biology. 3:913-917. (Pubitemid 32952256)
81. Ling YH, Li T, Perez-Soler R, Haigentz M, Jr. 2009. Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinib. Cancer Chemother Pharmacol. 64:539-548.
82. Liu G, Sengupta PK, Jamal B, Yang HY, Bouchie MP, Lindner V, Varelas X, Kukuruzinska MA. 2013. N-Glycosylation Induces the CTHRC1 protein and drives oral cancer cell migration. J Biol Chem. 288:20217-20227.
83. Liwosz A, Lei T, Kukuruzinska MA. 2006. N-Glycosylation affects the molecular organization and stability of E-cadherin junctions. J Biol Chem. 281:23138-23149.
84. Lui VW, Hedberg ML, Li H, Vangara BS, Pendleton K, Zeng Y, Lu Y, Zhang Q, Du Y, Gilbert BR, et al. 2013. Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discovery. 3:761-769.
85. Ma J, Saito H, Oka T, Vijay IK. 1996. Negative regulatory element involved in the hormonal regulation of GlcNAc-1-P transferase gene in mouse mammary gland. J Biol Chem. 271:11197-11203.
86. MacDonald BT, Tamai K, He X. 2009. Wnt/beta-catenin signaling: Components, mechanisms, and diseases. Dev Cell. 17:9-26.
87. Maeda O, Usami N, Kondo M, Takahashi M, Goto H, Shimokata K, Kusugami K, Sekido Y. 2004. Plakoglobin (gamma-catenin) has TCF/LEF familydependent transcriptional activity in beta-catenin-deficient cell line. Oncogene. 23:964-972. (Pubitemid 38250942)
88. Maher MT, Flozak AS, Stocker AM, Chenn A, Gottardi CJ. 2009. Activity of the beta-catenin phosphodestruction complex at cell-cell contacts is enhanced by cadherin-based adhesion. J Cell Biol. 186:219-228.
89. Maiden SL, Hardin J. 2011. The secret life of alpha-catenin: Moonlighting in morphogenesis. J Cell Biol. 195:543-552.
90. Mandal M, Myers JN, Lippman SM, Johnson FM, Williams MD, Rayala S, Ohshiro K, Rosenthal DI, Weber RS, Gallick GE, et al. 2008. Epithelial to mesenchymal transition in head and neck squamous carcinoma: Association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer. 112:2088-2100. (Pubitemid 351574086)
91. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 133:704-715. (Pubitemid 351636299)
92. Marek KW, Vijay IK, Marth JD. 1999. A recessive deletion in the GlcNAc-1-phosphotransferase gene results in peri-implantation embryonic lethality. Glycobiology. 9:1263-1271.
93. Massague J. 2008. TGFbeta in cancer. Cell. 134:215-230.
94. Mays RW, Nelson WJ, Marrs JA. 1995. Generation of epithelial cell polarity: Roles for protein trafficking, membrane-cytoskeleton, and E-cadherinmediated cell adhesion. Cold Spring Harb Symp Quant Biol. 60:763-773.
95. Meissner JD, Naumann A, Mueller WH, Scheibe RJ. 1999. Regulation of UDP-N-acetylglucosamine:dolichyl-phosphate N-acetylglucosamine-1-phosphate transferase by retinoic acid in P19 cells. Biochem J. 338(Pt 2):561-568.
96. Mendelsohn R, Cheung P, Berger L, Partridge E, Lau K, Datti A, Pawling J, Dennis JW. 2007. Complex N-glycan and metabolic control in tumor cells. Cancer Res. 67:9771-9780. (Pubitemid 47621224)
97. Mendelsohn RD, Helmerhorst EJ, Cipollo JF, Kukuruzinska MA. 2005. A hypomorphic allele of the first N-glycosylation gene, ALG7, causes mitochondrial defects in yeast. Biochim Biophys Acta. 1723:33-44. (Pubitemid 40744669)
98. Motahhary P, Baghaie F, Mamishi S, Pourakbari B, Mahmoudi S, Shakib PA. 2012. Mutational Status of FGFR3 in Oral Squamous Cell Carcinoma. J Dentistry. 9:7-13.
99. Nejsum LN, Nelson WJ. 2007. A molecular mechanism directly linking E-cadherin adhesion to initiation of epithelial cell surface polarity. J Cell Biol. 178:323-335. (Pubitemid 47076467)
100. Nemade RV, Bierie B, Nozawa M, Bry C, Smith GH, Vasioukhin V, Fuchs E, Hennighausen L. 2004. Biogenesis and function of mouse mammary epithelium depends on the presence of functional alpha-catenin. Mech Dev. 121:91-99. (Pubitemid 38050182)
101. Nita-Lazar M, Noonan V, Rebustini I, Walker J, Menko AS, Kukuruzinska MA. 2009. Overexpression of DPAGT1 leads to aberrant N-glycosylation of E-cadherin and cellular discohesion in oral cancer. Cancer Res. 69:5673-5680.
102. Nita-Lazar M, Rebustini I, Walker J, Kukuruzinska MA. 2010. Hypoglycosylated E-cadherin promotes the assembly of tight junctions through the recruitment of PP2A to adherens junctions. Exp Cell Res. 316:1871-1884.
103. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA. 2008. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 68:3645-3654.
104. Park EH, Kim S, Jo JY, Kim SJ, Hwang Y, Kim JM, Song SY, Lee DK, Koh SS. 2013. Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells. Carcinogenesis. 34(3):694-702.
105. Partridge EA, Le Roy C, Di Guglielmo GM, Pawling J, Cheung P, Granovsky M, Nabi IR, Wrana JL, Dennis JW. 2004. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science. 306:120-124. (Pubitemid 39451953)
106. Pinho SS, Figueiredo J, Cabral J, Carvalho S, Dourado J, Magalhaes A, Gartner F, Mendonca AM, Isaji T, Gu J, et al. 2013. E-cadherin and adherens-junctions stability in gastric carcinoma: Functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and V. Biochim Biophys Acta. 1830:2690-2700.
107. Pinho SS, Oliveira P, Cabral J, Carvalho S, Huntsman D, Gartner F, Seruca R, Reis CA, Oliveira C. 2012. Loss and recovery of Mgat3 and GnT-III mediated E-cadherin N-glycosylation is a mechanism involved in epithelial-mesenchymal- epithelial transitions. PLoS ONE. 7:e33191.
108. Pinho SS, Reis CA, Paredes J, Magalhaes AM, Ferreira AC, Figueiredo J, Xiaogang W, Carneiro F, Gartner F, Seruca R. 2009. The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin. Hum Mol Genet. 18:2599-2608.
109. Polakis P. 2000. Wnt signaling and cancer. Genes Dev. 14:1837-1851. (Pubitemid 30639518)
110. Polyak K, Weinberg RA. 2009. Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer. 9:265-273.
111. Pretel R, Lennon K, Bird A, Kukuruzinska MA. 1995. Expression of the first N-glycosylation gene in the dolichol pathway, ALG7, is regulated at two major control points in the G1 phase of the Saccharomyces cerevisiae cell cycle. Exp Cell Res. 219:477-486.
112. Prime SS, Davies M, Pring M, Paterson IC. 2004. The role of TGF-beta in epithelial malignancy and its relevance to the pathogenesis of oral cancer (part II). Crit Rev Oral Biol Med. 15:337-347. (Pubitemid 44567522)
113. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE. 2007. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA. 104:973-978. (Pubitemid 46154721)
114. Rajasekaran AK, Hojo M, Huima T, Rodriguez-Boulan E. 1996. Catenins and zonula occludens-1 form a complex during early stages in the assembly of tight junctions. J Cell Biol. 132:451-463. (Pubitemid 26053448)
115. Rajput B, Muniappa N, Vijay IK. 1994. Developmental and hormonal regulation of UDP-GlcNAc:dolichol phosphate GlcNAc-1-P transferase in mouse mammary gland. J Biol Chem. 269:16054-16061. (Pubitemid 24209291)
116. Regis S, Dagnino F, Caroli F, Filocamo M. 2002. Genomic structure of the human UDP-GlcNAc:dolichol-P GlcNAc-1-P transferase gene. DNA Seq. 13:245-250. (Pubitemid 35293840)
117. Rine J, Hansen W, Hardeman E, Davis RW. 1983. Targeted selection of recombinant clones through gene dosage effects. Proc Natl Acad Sci USA. 80:6750-6754. (Pubitemid 14243225)
118. Rini J, Esko J, Varki A. 2009. Glycosyltransferases and glycan-processing enzymes. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, editors. Essentials of Glycobiology. Cold Spring Harbor (NY): Cold Spring Harbor Press.
119. Rothenberg SM, Ellisen LW. 2012. The molecular pathogenesis of head and neck squamous cell carcinoma. J Clin Invest. 122:1951-1957.
120. Rudiger M. 1998. Vinculin and alpha-catenin: Shared and unique functions in adherens junctions. Bioessays. 20:733-740. (Pubitemid 28485900)
121. Sandulache VC, Ow TJ, Pickering CR, Frederick MJ, Zhou G, Fokt I, Davis-Malesevich M, Priebe W, Myers JN. 2011. Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells. Cancer. 117:2926-2938.
122. Sano D, Xie TX, Ow TJ, Zhao M, Pickering CR, Zhou G, Sandulache VC, Wheeler DA, Gibbs RA, Caulin C, et al. 2011. Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer. Clin Cancer Res. 17:6658-6670.
123. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K, Birchmeier W. 1991. E-cadherin expression in squamous cell carcinomas of head and neck: Inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res. 51:6328-6337.
124. Schwitalla S, Fingerle AA, Cammareri P, Nebelsiek T, Goktuna SI, Ziegler PK, Canli O, Heijmans J, Huels DJ, Moreaux G, et al. 2013. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell. 152:25-38.
125. Sengupta PK, Bouchie MP, Kukuruzinska MA. 2010. N-Glycosylation gene DPAGT1 is a target of the Wnt/beta-catenin signaling pathway. J Biol Chem. 285:31164-31173.
126. Sengupta PK, Bouchie MP, Nita-Lazar M, Yang HY, Kukuruzinska MA. 2013. Coordinate regulation of N-glycosylation gene DPAGT1, canonical Wnt signaling and E-cadherin adhesion. J Cell Sci. 126:484-496.
127. Shimizu M, Fukunaga Y, Ikenouchi J, Nagafuchi A. 2008. Defining the roles of beta-catenin and plakoglobin in LEF/T-cell factor-dependent transcription using beta-catenin/plakoglobin-null F9 cells. Mol Cell Biol. 28:825-835.
128. Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T. 2005. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells. Cancer Res. 65:6364-6370. (Pubitemid 40994423)
129. Sontag E. 2001. Protein phosphatase 2A: The Trojan Horse of cellular signaling. Cell Signal. 13:7-16. (Pubitemid 32222967)
130. Stanley P, Schachter H, Taniguchi N. 2009. N-Glycans. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, editors. Essentials of Glycobiology. Cold Spring Harbor (NY): Cold Spring Harbor Press.
131. Stehbens SJ, Paterson AD, Crampton MS, Shewan AM, Ferguson C, Akhmanova A, Parton RG, Yap AS. 2006. Dynamic microtubules regulate the local concentration of E-cadherin at cell-cell contacts. J Cell Sci. 119:1801-1811. (Pubitemid 43811006)
132. Stockinger A, Eger A, Wolf J, Beug H, Foisner R. 2001. E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity. J Cell Biol. 154:1185-1196. (Pubitemid 34286196)
133. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, et al. 2011. The mutational landscape of head and neck squamous cell carcinoma. Science. 333:1157-1160.
134. Takeichi M. 1991. Cadherin cell-adhesion receptors as a morphogenetic regulator. Science. 251:1451-1455. (Pubitemid 121000430)
135. Tang L, Dai DL, Su M, Martinka M, Li G, Zhou Y. 2006. Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers. Clin Cancer Res. 12:3716-3722. (Pubitemid 44000252)
136. Tar K, Birukova AA, Csortos C, Bako E, Garcia JGN, Verin AD. 2004. Phosphatase 2A is involved in endothelial cell microtubule remodeling and barrier regulation. J Cell Biochem. 92:534-546.
137. Timal S, Hoischen A, Lehle L, Adamowicz M, Huijben K, Sykut-Cegielska J, Paprocka J, Jamroz E, van Spronsen FJ, Korner C, et al. 2012. Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing. Hum Mol Genet. 21:4151-4161.
138. Tkacz JS, Lampen O. 1975. Tunicamycin inhibition of polyisoprenyl N-acetylglucosaminyl pyrophosphate formation in calf-liver microsomes. Biochem Biophys Res Commun. 65:248-257.
139. Twiss F, Le Duc Q, Van Der Horst S, Tabdili H, Van Der Krogt G, Wang N, Rehmann H, Huveneers S, Leckband DE, De Rooij J. 2012. Vinculin-dependent Cadherin mechanosensing regulates efficient epithelial barrier formation. Biol Open. 1:1128-1140.
140. Vagin O, Tokhtaeva E, Yakubov I, Shevchenko E, Sachs G. 2008. Inverse correlation between the extent of N-glycan branching and intercellular adhesion in epithelia-Contribution of the Na,K-ATPase beta(1) subunit. J Biol Chem. 283:2192-2202.
141. Valastyan S, Weinberg RA. 2011. Tumor metastasis: Molecular insights and evolving paradigms. Cell. 147:275-292.
142. Varki A, Freeze HH. 2009. Glycans in acquired human diseases. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, editors. Essentials of Glycobiology. Cold Spring Harbor (NY): Cold Spring Harbor Press.
143. Varki A, Kannagi R, Toole BP. 2009. Glycosylation changes in cancer. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, editors. Essentials of Glycobiology. Cold Spring Harbor (NY): Cold Spring Harbor Press.
144. Varki A, Lowe JB. 2009. Biological roles of glycans. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, editors. Essentials of Glycobiology. Cold Spring Harbor (NY): Cold Spring Harbor Press.
145. Vasioukhin V, Bauer C, Degenstein L, Wise B, Fuchs E. 2001. Hyperproliferation and defects in epithelial polarity upon conditional ablation of alphacatenin in skin. Cell. 104:605-617. (Pubitemid 32201954)
146. Wang D, Su L, Huang D, Zhang H, Shin DM, Chen ZG. 2011. Downregulation of E-Cadherin enhances proliferation of head and neck cancer through transcriptional regulation of EGFR. Mol Cancer. 10:116.
147. Wang P, Wang YC, Chen XY, Shen ZY, Cao H, Zhang YJ, Yu J, Zhu JD, Lu YY, Fang JY. 2012. CTHRC1 is upregulated by promoter demethylation and transforming growth factor-beta1 and may be associated with metastasis in human gastric cancer. Cancer Sci. 103:1327-1333.
148. Ward PS, Thompson CB. 2012. Metabolic reprogramming: A cancer hallmark even warburg did not anticipate. Cancer Cell. 21:297-308.
149. Watabe-Hchida M, Uchida N, Imamura Y, Nagafuchi A, Fujimoto K, Uemura T, Vermeulen S, van Roy F, Adamson ED, Takeichi M. 1998. Alpha-Catenin-vinculin interaction functions to organize the apical junctional complex in epithelial cells. J Cell Biol. 142:847-857. (Pubitemid 28381500)
150. Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA. 2002. Altered expression of E-cadherin in hepatocellular carcinoma: Correlations with genetic alterations, beta-catenin expression, and clinical features. Hepatology. 36:692-701. (Pubitemid 34977181)
151. Welply JK, Lau JT, Lennarz WJ. 1985. Developmental regulation of glycosyltransferases involved in synthesis of N-linked glycoproteins in sea urchin embryos. Dev Biol. 107:252-258. (Pubitemid 15157434)
152. Wend P, Fang L, Zhu Q, Schipper JH, Loddenkemper C, Kosel F, Brinkmann V, Eckert K, Hindersin S, Holland JD, et al. 2013. Wnt/beta-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours. EMBO J. 32:1977-1989.
153. Wend P, Holland JD, Ziebold U, Birchmeier W. 2010. Wnt signaling in stem
154. Wheeler SE, Suzuki S, Thomas SM, Sen M, Leeman-Neill RJ, Chiosea SI, Kuan CT, Bigner DD, Gooding WE, Lai SY, et al. 2010. Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation. Oncogene. 29:5135-5145.
155. Wheelock MJ, Johnson KR. 2003. Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol. 19:207-235. (Pubitemid 37487348)
156. Wodarz A, Nathke I. 2007. Cell polarity in development and cancer. Nat Cell Biol. 9:1016-1024. (Pubitemid 47342312)
157. Wu ZQ, Li XY, Hu CY, Ford M, Kleer CG, Weiss SJ. 2012. Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression. Proc Natl Acad Sci USA. 109:16654-16659.
158. Wu X, Rush JS, Karaoglu D, Krasnewich D, Lubinsky MS, Waechter CJ, Gilmore R, Freeze HH. 2003. Deficiency of UDP-GlcNAc:dolichol phosphate N-acetylglucosamine-1 phosphate transferase (DPAGT1) causes a novel congenital disorder of glycosylation type Ij. Hum Mutat. 22:144-150. (Pubitemid 36950812)
159. Xu Q, Akama R, Isaji T, Lu Y, Hashimoto H, Kariya Y, Fukuda T, Du Y, Gu J. 2011. Wnt/beta-catenin signaling down-regulates N- acetylglucosaminyltransferase III expression: The implications of two mutually exclusive pathways for regulation. J Biol Chem. 286:4310-4318.
160. Yamamoto S, Nishimura O, Misaki K, Nishita M, Minami Y, Yonemura S, Tarui H, Sasaki H. 2008. Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex. Dev Cell. 15:23-36. (Pubitemid 351895602)
161. Zawacka-Pankau J, Grinkevich VV, Hunten S, Nikulenkov F, Gluch A, Li H, Enge M, Kel A, Selivanova G. 2011. Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: Targeting Warburg effect to fight cancer. J Biol Chem. 286:41600-41615.
162. Zhang XL, Qu XJ, Vijay IK. 2003. STAT5a regulates the GlcNAc-1-phosphate transferase gene transcription and expression. Cell Physiol Biochem. 13:85-92. (Pubitemid 36359437)
163. Zhurinsky J, Shtutman M, Ben-Ze'ev A. 2000. Plakoglobin and beta-catenin: Protein interactions, regulation and biological roles. J Cell Sci. 113(Pt 18):3127-3139.